First-in-class approved phosphoinositide-3-kinase inhibitor Alpelesib (BYL 719): Examination of disease-specific activity in human tumor 3 dimensional primary culture organoids
Journal article published in 2020 by
Robert Alan Nagourney,
Adam J. Nagourney,
Peter Tran 
,
Paula Bernard,
Federico Francisco,
Steven S. Evans
,
Paula Bernard,
Federico Francisco,
Steven S. Evans
